BridgeMD
New treatment option for Breast Neoplasms
Official title Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients
ClinicalTrials.gov ID: NCT05494502
What this study is testing
- What it's testing
- Chronic postsurgical pain (CPSP) has an incidence of 46% in patients after breast cancer surgery, which seriously affects patients' physiological and psychological function, as well as quality of life. Acute pain is an independent risk factor for persistent pain after surgery.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Age of 18 years or over, but less than 85 years;
- Scheduled to undergo mastectomy for primary unilateral breast cancer.
You likely can't join if
- Previous breast cancer surgery with an incision of \>2 cm;
- Chronic opioid dependence or long-term intake of analgesic medicines (\>3 months);
- Any contraindication to erector spinae plane block, including intrathoracic infection, infection at the puncture site, cancer invasion of the...
- Inability to communicate in the preoperative period because of profound dementia, deafness, language barriers, or end-stage disease;
- History of malignant tumor in other organs, or a current combination of malignant tumor of other organs;
- History of coronary heart disease (diagnosed coronary stenosis, previous myocardial infarction, previous percutaneous coronary intervention or...
See the full eligibility criteria
- Age of 18 years or over, but less than 85 years;
- Scheduled to undergo mastectomy for primary unilateral breast cancer.
- Previous breast cancer surgery with an incision of \>2 cm;
- Chronic opioid dependence or long-term intake of analgesic medicines (\>3 months);
- Any contraindication to erector spinae plane block, including intrathoracic infection, infection at the puncture site, cancer invasion of the puncture site, severe spinal deformity, history of spinal surgery, and severe...
- Inability to communicate in the preoperative period because of profound dementia, deafness, language barriers, or end-stage disease;
- History of malignant tumor in other organs, or a current combination of malignant tumor of other organs;
- History of coronary heart disease (diagnosed coronary stenosis, previous myocardial infarction, previous percutaneous coronary intervention or coronary artery bypass grafting); preoperative hepatic or renal impairment...
- Allergy to ropivacaine.
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.